Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of the Incidence of Hyperoxia and the Effectiveness of FiO2 Titration Guided by the Oxygen Reserve Index in Preventing Hyperoxia.

NCT05770583 is registered in ClinicalTrials.gov with Tepecik Training and Research Hospital as lead sponsor.

NCT NCT05770583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05770583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of the Incidence of Hyperoxia and the Effectiveness of FiO2 Titration Guided by the Oxygen Reserve Index in Preventing Hyperoxia.
Lead sponsor
Tepecik Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2020
Completion date
March 5, 2023
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication, hyperoxia